Financhill
Back

Lexaria Bioscience 10K Form

Sell
30

LEXX
Lexaria Bioscience

Last Price:
$0.88
Seasonality Move:
-1.11%

7 Day Trial

ALL ACCESS PASS

$ 7

Receive LEXX News And Ratings

See the #1 stock for the next 7 days that we like better than LEXX

LEXX Financial Statistics

Sales & Book Value

Annual Sales: $464.3K
Cash Flow: $-3.6M
Price / Cash Flow: 0
Annual Sales: $0.28
Price / Book: 3.06

Profitability

EPS (TTM): -0.67000
Net Income (TTM): $-11.4M
Gross Margin: $459.5K
Return on Equity: -147.06%
Return on Assets: -129.15%

Lexaria Bioscience Earnings Forecast

Key Lexaria Bioscience Financial Ratios

  • The Gross Profit Margin over the past 19 years for LEXX is 98.96%.
  • The Selling, General & Administrative Expenses for LEXX have been equal to 829.68% of Gross Profit Margin.
  • The Research & Development expenses have been 508.44% of Revenue.
  • The Net Earning history of LEXX is -1,248.24% of Total Revenues.
  • Per Share Earnings over the last 20 years have been positive in 11 years.

Lexaria Bioscience Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Pharmaceuticals
Sector: Health Care
Current Symbol: LEXX
Website: lexariabioscience.com

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 3.9
Quick Ratio: 3.35

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

LEXX Technical Analysis vs Fundamental Analysis

Sell
30
Lexaria Bioscience (LEXX) is a Sell

Is Lexaria Bioscience a Buy or a Sell?